Frontocortical N-acetylaspartate reduction associated with long-term i.v. heroin use.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11805264.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To examine possible metabolic frontal lobe alterations in i.v. heroin-dependent patients with different histories of concomitant substance use, N-acetylaspartate (NAA), a putative marker of neuronal viability, was measured by (1)H-MRS. Compared with controls, NAA levels in patients were reduced by 7% in gray matter (p = 0.015) but not in white matter. To what extent comorbid conditions or substance use, including alcohol, contributed to these frontocortical metabolic changes remains to be elucidated.
Medical subject headings
- Aspartic Acid
- Frontal Lobe
- Heroin Dependence